Evidence mapPaperPMID 40535596Full record

ArticleInternational journal of cardiology. Heart & vasculature2025

Tricuspid regurgitation and chronic kidney disease in patients with cardiogenic shock: Review of the literature and real-world experience from a single center.

Daniel Oren, Sunil Ramchandani, Adrian Lorenzana, Ranjit Nair, Julia Szinte, Kian Maalizadeh, Farage Ftiha, Cathrine M Moeller, Andrea Fernandez-Valledor, Roi Bar Cohen and 9 more

Abstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Daniel OrenDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Sunil RamchandaniDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Adrian LorenzanaDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Ranjit NairDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Julia SzinteDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Kian MaalizadehDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Farage FtihaDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Cathrine M MoellerDepartment of Medicine, Icahn School of Medicine at Mount Sinai West and St. Luke's Hospitals, NY, USA.
Andrea Fernandez-ValledorDivision of Cardiology, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Roi Bar CohenDivision of Cardiology, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Ignacio ZepedaDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Shudhanshu AlishettiDivision of Cardiology, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Nino MihatovDivision of Cardiology, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Kumudha RamasubbuDivision of Cardiology, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Ruth MinkinDivision of Pulmonary and Critical Care, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Anthony SalehDivision of Pulmonary and Critical Care, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Manish A ParikhDivision of Cardiology, Department of Medicine, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Franklyn FentonDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.
Stephen J PetersonDepartment of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic kidney disease (CKD) frequently complicates Congestive Heart Failure (CHF) and can worsen outcomes in cardiogenic shock. Tricuspid Regurgitation (TR), by elevating central venous pressure, may exacerbate renal impairment. Limited data exist regarding CKD's influence in TR interventions. This study assesses the impact of CKD on survival and explores RV dysfunction as a potential mediator in patients with TR in cardiogenic shock. Methods: We retrospectively analyzed patients admitted with HF-related or myocardial infarction-induced cardiogenic shock (2021-2025). Patients were stratified by TR severity (none/trivial, mild, moderate, severe) and CKD stage. Echocardiographic, laboratory, and hemodynamic data were collected. RV dysfunction was assessed using echocardiography and right heart catheterization. Survival outcomes, including HF readmissions and mortality, were evaluated using Kaplan-Meier analysis and Cox regression, considering predictors significant at p < 0.10. Results: Among 177 patients (median age 70 years, EF 35 %, 46 % Black), 55 % had CKD. TR severity distribution was: none/trivial 42 %, mild 16 %, moderate 22 %, and severe 20 %. Severe TR significantly increased in-hospital mortality (40 %) compared to non-severe TR (24 %) and correlated with worsening CKD stages. HF readmissions within 12 months occurred in 10 % of patients. Older age and RV dysfunction emerged as the strongest mortality predictors. Severe TR independently increased mortality and readmission risk. Conclusion: Severe TR significantly worsens survival in cardiogenic shock patients, especially those with advanced CKD, mediated by RV dysfunction. CKD severity assessment may enhance patient stratification for valve interventions. Randomized studies are required to further validate these findings.

Indexed as

Cardiogenic shockChronic kidney diseaseRight ventricular failureTricuspid regurgitation

Identifiers

PMID40535596
PMCPMC12175724

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.